RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer

Background: Abnormal regulation of genes has been closely related to gastric cancer. The characterization of gastric cancer has necessitated the development of new therapeutics as well as the identification of prognostic markers to predict the response to novel drugs. In our study, we used RNA seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Sung-Hwa, Sul, Hee Jung, Kim, Bohyun, Kim, Hyeong Su, Kim, Bum Jun, Lim, Hyun, Kang, Ho Suk, Soh, Jae Seung, Kim, Kab Choong, Cho, Ji Woong, Seo, Jinwon, Koh, Youngho, Zang, Dae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210561/
https://www.ncbi.nlm.nih.gov/pubmed/34149925
http://dx.doi.org/10.7150/jca.56014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210561/
https://www.ncbi.nlm.nih.gov/pubmed/34149925
http://dx.doi.org/10.7150/jca.56014

Ejemplares similares